F19.159
Other psychoactive substance abuse with psychoactive substance-induced psychotic disorder, unspecified
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code F19.159 refers to a condition characterized by the abuse of various neuroactive substances, leading to a psychotic disorder that is induced by these substances. This diagnosis covers situations where an individual consumes psychoactive substances — such as certain drugs or chemicals — resulting in mental disturbances that include hallucinations, delusions, or disorganized thinking. The term 'unspecified' indicates that the exact nature or severity of the psychotic disorder has not been detailed. Understanding this condition is crucial for awareness and treatment planning, as it affects mental health and daily functioning.
Causes & Symptoms
Clinical Causes: Use of psychoactive substances like opioids, stimulants, sedatives, hallucinogens, or inhalants Prolonged or high-dose consumption of substances that alter brain chemistry Combination of multiple psychoactive drugs Underlying mental health issues that may predispose to substance abuse Social or environmental factors contributing to substance misuse
Key Symptoms: Hallucinations, such as seeing or hearing things that are not present Delusional beliefs that are not based in reality Disorganized speech or difficulty maintaining coherent conversation Aggressive or violent behavior Confusion or impaired consciousness Paranoia or mistrust of others Emotional instability, including rapid mood swings Sleep disturbances or insomnia Impaired judgment or decision-making Physical signs related to substance use, like dilated pupils, altered heart rate, or tremors
Diagnostic & Treatment
Diagnosis Path: Diagnosis of F19.159 involves a comprehensive psychiatric assessment, including a detailed medical history, substance use history, and mental status examination. Healthcare providers may also perform laboratory tests such as blood or urine screenings to detect specific psychoactive substances. It is important to distinguish this condition from primary psychotic disorders not caused by substances. Medical professionals may utilize diagnostic criteria from psychiatric manuals and consider the timing of substance use relative to the onset of psychotic symptoms.
Treatment Protocols: Treatment strategies generally focus on managing both substance abuse and the psychotic symptoms. Approaches can include: - **Detoxification**: Medical supervision to safely withdraw from the psychoactive substance - **Medication**: Antipsychotics to control hallucinations and delusions, and medications to support sobriety - **Psychotherapy**: Cognitive-behavioral therapy to address underlying issues and develop coping skills - **Support groups**: Peer support and counseling to prevent relapse - **Rehabilitation programs**: Long-term rehab to support sustained recovery and prevent future substance abuse Effective treatment depends on individual circumstances, including the type of substance abused and the severity of psychotic symptoms. A multidisciplinary approach involving healthcare providers from psychiatry, psychology, and addiction services can offer the most comprehensive care.
Clinical Advice & FAQs
Billing Guidance
Is F19.159 a billable ICD-10 code?
Yes, F19.159 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F19.159?
Clinical documentation must specify the nature of Other psychoactive substance abuse with psychoactive substance-induced psychotic disorder, unspecified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference